Miami, FLORIDA9 Active Studies

Prurigo Nodularis Clinical Trials in Miami, FLORIDA

Find 9 actively recruiting prurigo nodularis clinical trials in Miami, FLORIDA. Connect with local research sites and explore new treatment options.

9
Active Trials
6
Sponsors
6,956
Enrolling

Recruiting Prurigo Nodularis Studies in Miami

RecruitingMiami, FLORIDANCT06824194

Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

This study is a Phase 3, randomized, modified double-blind study which aims to document the safety profile of the PCV21 vaccine (investigational pneumococcal vaccine) compared to a licensed 20-valent ...

2,320 participants
Sanofi
View Study Details
RecruitingMiami, FLORIDANCT06736041

Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

This study is a Phase 3, randomized, modified double-blind study which aims to measure whether PCV21 vaccine (investigational pneumococcal conjugate vaccine) is safe and can help the body to develop g...

1,630 participants
Sanofi Pasteur, a Sanofi Company
View Study Details
RecruitingMiami, FLORIDANCT06838000

Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents

The purpose of this study is to evaluate the safety and immunogenicity of PCV21 versus 20vPCV ( 20-valent pneumococcal conjugate vaccine, Prevnar 20) for catch-up vaccination in infants (7 to 11 MoA-M...

1,252 participants
Sanofi Pasteur, a Sanofi Company
View Study Details
RecruitingMiami, FLORIDANCT06824181

Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

This study is a Phase 3, randomized, modified double-blind study which aims to measure whether the investigational pneumococcal conjugate vaccine PCV21 is safe and can help the body to develop germ-fi...

580 participants
Sanofi
View Study Details
RecruitingMiami, FLORIDANCT06527404

A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis

The main objective of the study will be to evaluate the efficacy of rocatinlimab compared with placebo at week 24 on the patient-reported outcome (PRO) measure of pruritus and overall clinical assessm...

460 participants
Amgen
View Study Details
RecruitingMiami, FLORIDANCT06516952

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis....

330 participants
Incyte Corporation
View Study Details
RecruitingMiami, FLORIDANCT05263206

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

The main objective of the study is to assess efficacy and safety of dupilumab given up to 24 weeks in adults with CPUO. This is a master protocol which includes 2 parallel-treatment, double-blind, 2-...

284 participants
Sanofi
View Study Details
RecruitingMiami, FLORIDANCT06776432

Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea

The primary purpose of this study is to evaluate the effectiveness of sivopixant, acetazolamide and SASS-001 in adults with sleep apnea with a central component....

60 participants
Shionogi Apnimed Sleep Science
View Study Details
RecruitingMiami, FLORIDANCT06785454

A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension

The primary purpose of the study is to assess the effect of lorundrostat taken orally (po) once a day on the Apnea-Hypopnea Index (AHI) in participants with moderate to severe obstructive sleep apnea ...

40 participants
Mineralys Therapeutics Inc.
View Study Details

About Prurigo Nodularis Clinical Trials in Miami

Prurigo nodularis is a chronic skin condition characterized by intensely itchy, hard lumps on the skin that develop from repeated scratching. It significantly impacts quality of life and sleep. Treatment includes topical therapies, phototherapy, and newer targeted biologics.

There are currently 9 prurigo nodularis clinical trials recruiting participants in Miami, FLORIDA. These studies are seeking a combined 6,956 participants. Research is being sponsored by Sanofi, Sanofi Pasteur, a Sanofi Company, Amgen and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Prurigo Nodularis Clinical Trials in Miami — FAQ

Are there prurigo nodularis clinical trials in Miami?

Yes, there are 9 prurigo nodularis clinical trials currently recruiting in Miami, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Miami?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.

Are clinical trials in Miami free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.

What prurigo nodularis treatments are being tested?

The 9 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for prurigo nodularis.

Data updated March 2, 2026 from ClinicalTrials.gov